These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24135200)

  • 21. Antidepressant effects assessed using behavior maintained under a differential-reinforcement-of-low-rate (DRL) operant schedule.
    O'Donnell JM; Marek GJ; Seiden LS
    Neurosci Biobehav Rev; 2005; 29(4-5):785-98. PubMed ID: 15893376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different effects of 5-HT receptor agonists on operant response in rats under DRL 10-s and DRL 30-s schedules.
    Liao RM; Chang YH
    Proc Natl Sci Counc Repub China B; 2001 Oct; 25(4):223-32. PubMed ID: 11699570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quinpirole, 8-OH-DPAT and ketanserin modulate catalepsy induced by high doses of atypical antipsychotics.
    Ninan I; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):603-8. PubMed ID: 10669905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of risperidone, clozapine and the 5-HT6 antagonist GSK-742457 on PCP-induced deficits in reversal learning in the two-lever operant task in male Sprague Dawley rats.
    de Bruin NM; van Drimmelen M; Kops M; van Elk J; Wetering MM; Schwienbacher I
    Behav Brain Res; 2013 May; 244():15-28. PubMed ID: 23384714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Add-on clinical effects of selective antagonist of 5HT6 receptors AVN-211 (CD-008-0173) in patients with schizophrenia stabilized on antipsychotic treatment: pilot study.
    Morozova MA; Lepilkina TA; Rupchev GE; Beniashvily AG; Burminskiy DS; Potanin SS; Bondarenko EV; Kazey VI; Lavrovsky Y; Ivachtchenko AV
    CNS Spectr; 2014 Aug; 19(4):316-23. PubMed ID: 23768250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of 5-HT6 receptor antagonism and cholinesterase inhibition in models of cognitive impairment in the rat.
    Marcos B; Chuang TT; Gil-Bea FJ; Ramirez MJ
    Br J Pharmacol; 2008 Oct; 155(3):434-40. PubMed ID: 18622410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. JNJ-10181457, a selective non-imidazole histamine H(3) receptor antagonist, normalizes acetylcholine neurotransmission and has efficacy in translational rat models of cognition.
    Galici R; Boggs JD; Aluisio L; Fraser IC; Bonaventure P; Lord B; Lovenberg TW
    Neuropharmacology; 2009 Jun; 56(8):1131-7. PubMed ID: 19345233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Olanzapine: preclinical pharmacology and recent findings.
    Moore NA
    Br J Psychiatry Suppl; 1999; (37):41-4. PubMed ID: 10211141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholinergic gating of hippocampal auditory evoked potentials in freely moving rats.
    Klinkenberg I; Sambeth A; Blokland A
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):988-97. PubMed ID: 22974558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Towards an animal model of an antipsychotic drug-resistant cognitive impairment in schizophrenia: scopolamine induces abnormally persistent latent inhibition, which can be reversed by cognitive enhancers but not by antipsychotic drugs.
    Barak S; Weiner I
    Int J Neuropsychopharmacol; 2009 Mar; 12(2):227-41. PubMed ID: 18687163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. M100907, a selective 5-HT2A receptor antagonist and a potential antipsychotic drug, facilitates N-methyl-D-aspartate-receptor mediated neurotransmission in the rat medial prefrontal cortical neurons in vitro.
    Arvanov VL; Wang RY
    Neuropsychopharmacology; 1998 Mar; 18(3):197-209. PubMed ID: 9471117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. M100907 and clozapine, but not haloperidol or raclopride, prevent phencyclidine-induced blockade of NMDA responses in pyramidal neurons of the rat medial prefrontal cortical slice.
    Wang RY; Liang X
    Neuropsychopharmacology; 1998 Jul; 19(1):74-85. PubMed ID: 9608579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of stretching behaviour induced by the selective 5-HT6 receptor antagonist, Ro 04-6790, in rats.
    Bentley JC; Bourson A; Boess FG; Fone KC; Marsden CA; Petit N; Sleight AJ
    Br J Pharmacol; 1999 Apr; 126(7):1537-42. PubMed ID: 10323584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delta9-Tetrahydrocannabinol-induced cognitive deficits are reversed by olanzapine but not haloperidol in rats.
    Egashira N; Ishigami N; Mishima K; Iwasaki K; Oishi R; Fujiwara M
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):499-506. PubMed ID: 18029074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antagonism of anticholinesterase (DFP) toxicity by donepezil plus scopolamine: a preliminary study.
    Janowsky DS; Davis JM; Overstreet DH
    Pharmacol Biochem Behav; 2004 Feb; 77(2):337-43. PubMed ID: 14751462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of serotonin in antipsychotic drug action.
    Meltzer HY
    Neuropsychopharmacology; 1999 Aug; 21(2 Suppl):106S-115S. PubMed ID: 10432496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of cholinesterase inhibitors, donepezil and rivastigmine on the acquisition, expression, and reinstatement of morphine-induced conditioned place preference in rats.
    Gawel K; Labuz K; Jenda M; Silberring J; Kotlinska JH
    Behav Brain Res; 2014 Jul; 268():169-76. PubMed ID: 24755308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of iloperidone, clozapine, and haloperidol on working memory of rats in the delayed non-matching-to-position paradigm.
    Gemperle AY; McAllister KH; Olpe HR
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):354-64. PubMed ID: 12827343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective 5-HT1A antagonists WAY 100635 and NAD-299 attenuate the impairment of passive avoidance caused by scopolamine in the rat.
    Misane I; Ogren SO
    Neuropsychopharmacology; 2003 Feb; 28(2):253-64. PubMed ID: 12589378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of adjunct galantamine to risperidone, or haloperidol, in animal models of antipsychotic activity and extrapyramidal side-effect liability: involvement of the cholinergic muscarinic receptor.
    Wadenberg ML; Fjällström AK; Federley M; Persson P; Stenqvist P
    Int J Neuropsychopharmacol; 2011 Jun; 14(5):644-54. PubMed ID: 20701827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.